Root Financial Partners’s Relay Therapeutics RLAY Stock Holding History

Root Financial Partners’s Portfolio RLAY Stock Details RLAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$925	Buy	+93	New	+$832	﹤0.01%	2639

Other funds holding RLAY

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Root Financial Partners's RLAY Position: Q1 2026 in Review

Root Financial Partners opened a new position in Relay Therapeutics (RLAY) in Q1 2026: 93 shares worth $925. The stake represents ﹤0.01% of the portfolio and ranks #2639 among its holdings.

242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

Root Financial Partners held 93 shares of Relay Therapeutics worth $925 as of Q1 2026.
Relay Therapeutics was a new Root Financial Partners position in Q1 2026.
Relay Therapeutics made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2639 holding.
242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.